Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments, and creams. It also develops, manufactures, and sells active pharmaceutical ingredients. In addition, the company provides specialty medicines for use in central nervous system and respiratory indications. Further, its products in the central nervous system and pain area comprise Copaxone for the treatment of relapsing forms of MS; AJOVY for the preventive treatment of migraine; and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington disease. Additionally, the company's products in the respiratory market include ProAir, ProAir Respiclick, QVAR, Duoresp Spiromax, Braltus, Cinqair/Cinqaero, and AirDuo RespiClick/ArmonAir RespiClick/AirDuo Digihaler for the treatment of asthma and chronic obstructive pulmonary disease, as well as Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim products in the oncology market. It has collaboration arrangements with Otsuka Pharmaceutical Co. Ltd. and Regeneron Pharmaceuticals, Inc. Teva Pharmaceutical Industries Limited was founded in 1901 and is headquartered in Petach Tikva, Israel. Show More...
-
Website http://www.tevapharm.com
-
Sector Healthcare
-
Industry Drug Manufacturers-Specialty & Generic
-
Last Quote 14.85 EUR
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share USD 3.67 3.09 2.25 1.49 3.56 1.82 0.07 -16.26 -2.35 -0.91 -0.75 Dividends USD 0.17 0.89 1.03 1.28 1.36 1.36 1.36 0.85 Payout Ratio % * 25.4 40.1 85.7 42.5 65.1 78.6 Shares Mil 921.0 893.0 873.0 850.0 858.0 864.0 961.0 1.016 1.021 1.091 1.093 Book Value Per Share * EUR 18.26 19.99 20.21 19.14 22.83 22.93 29.37 20.63 11.17 11.29 11.15 Free Cash Flow Per Share * EUR 2.73 2.43 2.86 2.51 3.13 5.17 4.7 2.32 3.02 -0.03 Return on Assets % 9.26 6.25 3.9 2.59 6.51 3.12 0.09 -20.21 -3.65 -1.69 -1.43 Financial Leverage (Average) 1.74 2.26 2.22 2.11 1.99 2.05 3.13 5.14 4.13 4.11 4.09 Return on Equity % 16.18 12.5 8.73 5.6 13.32 6.32 0.24 -76.07 -16.87 -6.97 -5.84 Return on Invested Capital % 13.19 8.87 6.01 4.17 9.67 5.05 0.94 -28.19 -3.46 -0.73 -0.46 Interest Coverage 17.2 20.32 6.12 4.98 13.13 9.71 2.51 -20.0 -1.82 -0.44 -0.37 Current Ratio 1.24 1.04 1.26 1.15 1.17 1.41 0.92 0.86 0.96 0.98 1.05 Quick Ratio 0.7 0.53 0.66 0.53 0.62 0.95 0.46 0.45 0.53 0.56 0.57 Debt/Equity 0.19 0.46 0.51 0.46 0.37 0.32 1.09 2.1 1.82 1.79 1.83